1. Hu, Jiao, Yu, Anze, Othmane, Belaydi, Chen, Jinbo, Zu, Xiongbing. 2021. Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer. In Theranostics, 11, 3089-3108. doi:10.7150/thno.53649. https://pubmed.ncbi.nlm.nih.gov/33537076/
2. Li, Tian-Jiao, Jin, Kai-Zhou, Li, Hao, Yu, Xian-Jun, Wu, Wei-Ding. 2022. SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer. In Cancer letters, 530, 142-155. doi:10.1016/j.canlet.2022.01.026. https://pubmed.ncbi.nlm.nih.gov/35077803/
3. Liang, Haifeng, Chen, Qing, Hu, Zhichao, Jiang, Libo, Dong, Jian. . Siglec15 facilitates the progression of non-small cell lung cancer and is correlated with spinal metastasis. In Annals of translational medicine, 10, 281. doi:10.21037/atm-22-764. https://pubmed.ncbi.nlm.nih.gov/35434017/
4. Wang, Jinchao, Xu, Linzong, Ding, Qian, Xu, Shangchen, Liu, Bin. 2023. Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas. In Frontiers in immunology, 14, 1065062. doi:10.3389/fimmu.2023.1065062. https://pubmed.ncbi.nlm.nih.gov/37325664/
5. Zhang, Yongxing, Sun, Hangxiang, Huang, Fei, Sun, Xuxu, Ye, Zhaoming. . The chromatin remodeling factor Arid1a cooperates with Jun/Fos to promote osteoclastogenesis by epigenetically upregulating Siglec15 expression. In Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 39, 775-790. doi:10.1093/jbmr/zjae042. https://pubmed.ncbi.nlm.nih.gov/38477755/
智鼠故事 
